The Straits Times
June 18, 2025 at 06:29 AM
A Nasdaq-listed stock focused on herbal medicine has spiked by more than 64,000% in 2025 despite making zero revenue.
The rally has transformed Hong Kong-based Regencell Bioscience Holdings from a penny stock to one worth more than $25.6 billion in market value. https://str.sg/NhZF
😮
😂
👍
❤️
😢
🙏
64